| scholarly article | Q13442814 |
| P50 | author | Pedro Baptista | Q42765256 |
| P2860 | cites work | Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis | Q35603145 |
| Challenges for clinical genetic DNA testing | Q35680316 | ||
| Venous thromboembolic disease: risk factors and laboratory investigation | Q35806681 | ||
| Development and integration of molecular genetic tests into clinical practice: the US experience | Q35821817 | ||
| Factor V Leiden: a disorder of factor V anticoagulant function | Q35838121 | ||
| Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population | Q38337767 | ||
| Optimal haplotype block-free selection of tagging SNPs for genome-wide association studies | Q39817287 | ||
| Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes | Q41809423 | ||
| Contribution of APOE promoter polymorphisms to Alzheimer's disease risk | Q43998196 | ||
| A multigene test for the risk of sporadic breast carcinoma | Q44415291 | ||
| Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer | Q44976008 | ||
| Does haplotype diversity predict power for association mapping of disease susceptibility? | Q48538210 | ||
| Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease | Q53239325 | ||
| Association mapping of complex diseases in linked regions: estimation of genetic effects and feasibility of testing rare variants | Q64048888 | ||
| Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias | Q74028329 | ||
| Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice | Q74741445 | ||
| Are rare variants responsible for susceptibility to complex diseases? | Q22337172 | ||
| Searching for genetic determinants in the new millennium | Q22337300 | ||
| A High-Density Admixture Map for Disease Gene Discovery in African Americans | Q24533390 | ||
| A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms | Q28203288 | ||
| Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening | Q28217255 | ||
| Commentary: meta-analysis of individual participants' data in genetic epidemiology | Q30707324 | ||
| Selecting tagging SNPs for association studies using power calculations from genotype data. | Q30951184 | ||
| A systematic review of genetic polymorphisms and breast cancer risk. | Q33766628 | ||
| The complexities of predictive genetic testing | Q33805238 | ||
| Association studies of genetic polymorphisms and complex disease | Q33838028 | ||
| Association of the DTNBP1 locus with schizophrenia in a U.S. population | Q33910454 | ||
| Risk models in genetic epidemiology | Q34222354 | ||
| Finding genes that underlie complex traits | Q35031309 | ||
| Genetic associations in large versus small studies: an empirical assessment | Q35070873 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 15-20 | |
| P577 | publication date | 2005-03-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
| P1476 | title | Principles in genetic risk assessment | |
| P478 | volume | 1 |
Search more.